Development of EBC46 for human tumors [ 2011 - 2012 ]

Also known as: Taking a cancer drug towards a clinical trial

Research Grant

[Cite as]

Researchers: Prof Peter Parsons (Principal investigator) ,  Dr Glen Boyle Dr Paul Reddell

Brief description EBC46 is a novel compound from the rain forest, being developed for cancer treatment by QBiotics Ltd and Queensland Institute of Medical Research. Injection of EBC46 into tumors in 5 different animal species rapidly destroyed the tumor, with good healing and no adverse effects. EBC46 therefore has potential for local control, perhaps cure, of a wide range of tumor types in humans.

Funding Amount $AUD 260,668.81

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]